58.26
price down icon2.72%   -1.63
after-market Handel nachbörslich: 58.26
loading

Kymera Therapeutics Inc Aktie (KYMR) Neueste Nachrichten

pulisher
Oct 14, 2025

Kymera Therapeutics’s Gollob sells $186k in shares - Investing.com

Oct 14, 2025
pulisher
Oct 14, 2025

What’s the recovery path for long term holders of Kymera Therapeutics Inc.2025 Institutional Moves & Growth Focused Investment Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Kymera Therapeutics Hits New 52-Week High at $60.00, Up 74.81% Year-to-Date - Markets Mojo

Oct 14, 2025
pulisher
Oct 14, 2025

Kymera Therapeutics director Albers sells $295k in shares By Investing.com - Investing.com Canada

Oct 14, 2025
pulisher
Oct 14, 2025

Kymera Therapeutics director Albers sells $295k in shares - Investing.com

Oct 14, 2025
pulisher
Oct 14, 2025

Advanced analytics toolkit walkthrough for Kymera Therapeutics Inc.2025 Retail Activity & Real-Time Volume Triggers - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Is Kymera Therapeutics Inc. stock attractive for ETFs2025 Trading Recap & Daily Growth Stock Investment Tips - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

What earnings revisions data tells us about Kymera Therapeutics Inc.Treasury Yields & Smart Investment Allocation Insights - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Kymera Therapeutics stock hits 52-week high at 59.03 USD By Investing.com - Investing.com Nigeria

Oct 13, 2025
pulisher
Oct 13, 2025

Kymera Therapeutics stock hits 52-week high at 59.03 USD - Investing.com India

Oct 13, 2025
pulisher
Oct 13, 2025

Will Kymera Therapeutics Inc. see short term momentumJuly 2025 Market Mood & Safe Entry Momentum Tips - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Custom strategy builders for tracking Kymera Therapeutics Inc.2025 Market Trends & Risk Adjusted Swing Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

Kymera Therapeutics Inc Stock Analysis and ForecastSupport and Resistance Levels & Free Stock Market Mentorship Programs - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Full technical analysis of Kymera Therapeutics Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Kymera Therapeutics (NASDAQ:KYMR) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Kymera Therapeutics Inc. stock chart pattern explainedFed Meeting & Daily Chart Pattern Signal Reports - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Ranking Kymera Therapeutics Inc. among high performing stocks via toolsWeekly Market Report & Risk Controlled Swing Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Should you hold or exit Kymera Therapeutics Inc. nowJuly 2025 Institutional & Real-Time Stock Movement Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Top chart patterns to watch in Kymera Therapeutics Inc.Market Trend Review & Community Verified Watchlist Alerts - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Strong Buy Ratings Propel a Promising 11.79% Upside - DirectorsTalk Interviews

Oct 07, 2025
pulisher
Oct 06, 2025

Kymera Therapeutics Hits New 52-Week High of $59.00, Up 69% - Markets Mojo

Oct 06, 2025
pulisher
Oct 06, 2025

Analyzing net buyer seller activity in Kymera Therapeutics Inc.Sell Signal & High Yield Stock Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Kymera Therapeutics Inc. stock maintain momentum in 20252025 Market WrapUp & Safe Capital Allocation Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Tools to monitor Kymera Therapeutics Inc. recovery probabilityMarket Growth Summary & Capital Protection Trading Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Keudell Morrison Wealth Management Invests $334,000 in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Oct 05, 2025
pulisher
Oct 03, 2025

Kymera Therapeutics stock hits 52-week high at $58.97 By Investing.com - Investing.com Nigeria

Oct 03, 2025
pulisher
Oct 03, 2025

Kymera Therapeutics stock hits 52-week high at $58.97 - Investing.com

Oct 03, 2025
pulisher
Oct 03, 2025

What analysts say about Kymera Therapeutics Inc stockGlobal Trade Effects & Low Risk Capital Growth Plans - earlytimes.in

Oct 03, 2025
pulisher
Oct 03, 2025

Analysts Set Kymera Therapeutics, Inc. (NASDAQ:KYMR) PT at $59.95 - Defense World

Oct 03, 2025
pulisher
Oct 02, 2025

Real time pattern detection on Kymera Therapeutics Inc. stockMarket Activity Summary & Consistent Profit Focused Trading Strategies - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Kymera Therapeutics (NASDAQ:KYMR) Given New $68.00 Price Target at Truist Financial - Defense World

Oct 02, 2025
pulisher
Oct 01, 2025

Oppenheimer Maintains Kymera Therapeutics (KYMR) Outperform Recommendation - Nasdaq

Oct 01, 2025
pulisher
Oct 01, 2025

Kymera Therapeutics Hits New 52-Week High of $58.93, Up 65.21% - Markets Mojo

Oct 01, 2025
pulisher
Oct 01, 2025

Is Codere Online Luxembourg SA a good long term investmentVolume Weighted Average Price & Learn the Basics of Investing in 5 Days - earlytimes.in

Oct 01, 2025
pulisher
Oct 01, 2025

Oppenheimer Raises Price Target for Kymera Therapeutics (KYMR) t - GuruFocus

Oct 01, 2025
pulisher
Oct 01, 2025

Kymera Overcomes Sanofi Deal Update, Marches Ahead With Pipeline - Nasdaq

Oct 01, 2025
pulisher
Oct 01, 2025

Oppenheimer Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Maintains Target Price $63 - 富途牛牛

Oct 01, 2025
pulisher
Oct 01, 2025

Kymera Therapeutics (NASDAQ:KYMR) Hits New 52-Week High Following Analyst Upgrade - MarketBeat

Oct 01, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):